BrightMindsBio

Historical 13F Holders

Symbol
DRUG
CUSIP
10919W405
All holders as of
Q2 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 10919W405 since 12/18/2024, largest first.

Filer % of Class Filed
Ian McDonald 13D/A 13.7% 7/2/2026
Event 11/4/2024
Janus Henderson Group PLC 13G/A 13.1% 5/15/2026
Event 3/31/2026
Cormorant Asset Management, LP 13G/A
9.2% 8/14/2026
Event 6/30/2026
Vivo Opportunity Fund Holdings, L.P. 13G/A
5.2% 5/12/2026
Event 3/31/2026
Vestal Point Capital, LP 13G
5.0% 5/15/2026
Event 3/31/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (6)
Perceptive Advisors LLC 13G/A
4.6% 2/17/2026
Event 12/31/2025
Adage Capital Management, L.P. 13G/A
3.4% 8/12/2026
Event 6/30/2026
Point72 Asset Management, L.P. 13G/A
3.0% 2/14/2025
Event 12/31/2024
RA Capital Management, L.P. 13G/A
2.9% 5/15/2025
Event 3/31/2025
Sio Capital Management, LLC 13G/A 2.7% 11/12/2025
Event 9/30/2025
Commodore Capital LP 13G/A
0.3% 2/17/2026
Event 12/31/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 4 95.0 $4.73 k
2026 Q2 101 9.32 M $654 M
2026 Q1 95 9.19 M $670 M
2025 Q4 75 6.59 M $515 M
2025 Q3 66 6.05 M $366 M
2025 Q2 49 5.24 M $137 M
2025 Q1 35 5.22 M $188 M
2024 Q4 32 4.90 M $176 M
2024 Q3 7 192 k $230 k
2024 Q2 7 198 k $208 k
2024 Q1 8 213 k $256 k
2023 Q4 9 228 k $330 k
2023 Q3 7 195 k $309 k